Hitoshi Yoshino

683 citations

27 papers · 528 indexed · h-index 13

Biomaterials top 10%
Endocrinology, Diabetes and Metabolism top 10%
- Hormonal and reproductive studies 6
Organic Chemistry top 10%
- Synthetic Organic Chemistry Methods 7
- Advanced Synthetic Organic Chemistry 4
- Asymmetric Synthesis and Catalysis 4
Pharmaceutical Science
Molecular Biology
Genetics
- Estrogen and related hormone effects 5
Pulmonary and Respiratory Medicine
- Prostate Cancer Treatment and Research 4
Oncology
- Cancer Treatment and Pharmacology 3
Cellular and Molecular Neuroscience
- Neuropeptides and Animal Physiology 3

Co-authors: Shin‐Ichiro Nishimura Keisuke Kurita Shigeru Ishii Satoshi Inoue Tetsuaki Tanaka Kazuo Murakami Masanori Fukazawa Yoshiyuki Suzuki
Cited by: Biomaterials Endocrinology, Diabetes and Metabolism Organic Chemistry
Journals: Proceedings of the National Academy of Sciences (1 paper)Diabetes (1 paper)Macromolecules (3 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Hitoshi Yoshino

26 papers receiving 505 citations

Peers

Countries citing papers authored by Hitoshi Yoshino

Since Specialization

Citations

This map shows the geographic impact of Hitoshi Yoshino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Yoshino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Yoshino more than expected).

Fields of papers citing papers by Hitoshi Yoshino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Yoshino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Yoshino. The network helps show where Hitoshi Yoshino may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hitoshi Yoshino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hitoshi Yoshino Line = papers co-authored together Hitoshi Yoshino links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist Proceedings of the National Academy of Sciences ·Takahiro Kawai,Bingfa Sun,Hitoshi Yoshino,Dan Feng,Yoshiyuki Suzuki,Masanori Fukazawa,Shunsuke Nagao,David B. Wainscott,Aaron D. Showalter,Brian A. Droz,Tong Sun Kobilka,Matthew P. Coghlan,Francis S. Willard,Yoshiki Kawabe,Brian K. Kobilka,Kyle W. Sloop	2020	123
2	OWL833, an Orally Active Nonpeptide GLP-1 Receptor Agonist, Improves Glucose Tolerance by Increasing Insulin Secretion and Reduces Food Intake of Cynomolgus Monkeys Diabetes ·Takahiro Kawai,FUMIHITO TANINO,Masanori Fukazawa,Kotaro Ogawa,Shunsuke Nagao,Hitoshi Yoshino,Shunichiro Komatsu,Yoshiyuki Suzuki,Yoshiki Kawabe	2018	10
3	CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells International Journal of Oncology ·Nobuyuki Ishikura,Hiromitsu Kawata,Ayako Nishimoto,Ryo Nakamura,Toshiaki Tsunenari,Miho Watanabe,Kazutaka Tachibana,Takuya Shiraishi,Hitoshi Yoshino,Akie Honma,Takashi Emura,Masateru Ohta,Toshito Nakagawa,Takao Houjo,Eva Corey,Robert L. Vessella,Yuko Aoki,Haruhiko Sato	2015	7
4	An orally available, small-molecule interferon inhibits viral replication Scientific Reports ·Hideyuki Konishi,Koichi Okamoto,Yusuke Ohmori,Hitoshi Yoshino,Hiroshi Ohmori,Motooki Ashihara,Yuichi Hirata,Atsunori Ohta,Hiroshi Sakamoto,Natsuko Hada,Asao Katsume,Michinori Kohara,Kazumi Morikawa,Takuo Tsukuda,Nobuo Shimma,Graham R. Foster,William Alazawi,Yuko Aoki,Mikio Arisawa,Masayuki Sudoh	2012	39
5	Biological properties of androgen receptor pure antagonist for treatment of castration‐resistant prostate cancer: Optimization from lead compound to CH5137291 The Prostate ·Hiromitsu Kawata,Shinichi Arai,Toshito Nakagawa,Nobuyuki Ishikura,Ayako Nishimoto,Hitoshi Yoshino,Takuya Shiraishi,Kazutaka Tachibana,Ryo Nakamura,Haruhiko Sato	2011	9
6	Efficient and Scalable Synthesis of Pyridine Sulfonamides Synlett ·Takashi Emura,Hitoshi Yoshino,Kazutaka Tachibana,Takuya Shiraishi,Akie Honma,Akemi Mizutani,Terushige Muraoka	2011	0
7	Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer Bioorganic & Medicinal Chemistry ·Hitoshi Yoshino,Haruhiko Sato,Takuya Shiraishi,Kazutaka Tachibana,Takashi Emura,Akie Honma,Nobuyuki Ishikura,Toshiaki Tsunenari,Miho Watanabe,Ayako Nishimoto,Ryo Nakamura,Toshito Nakagawa,Masateru Ohta,Noriyuki Takata,Kentaro Furumoto,Kazuya Kimura,Hiromitsu Kawata	2010	16
8	Structure–activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists Bioorganic & Medicinal Chemistry ·Hitoshi Yoshino,Haruhiko Sato,Kazutaka Tachibana,Takuya Shiraishi,Mitsuaki Nakamura,Masateru Ohta,Nobuyuki Ishikura,Masahiro Nagamuta,Etsuro Onuma,Toshito Nakagawa,Shinichi Arai,Koo-Hyeon Ahn,Kyung-Yun Jung,Hiromitsu Kawata	2010	14
9	Discovery of novel motilin antagonists: Conversion of tetrapeptide leads to orally available peptidomimetics Bioorganic & Medicinal Chemistry Letters ·Naoki Taka,Hiroharu Matsuoka,Tsutomu Sato,Hitoshi Yoshino,Ikuhiro Imaoka,Haruhiko Sato,Ken-ichiro Kotake,Yoshikazu Kumagai,Kenshi Kamei,Kenichi Ozaki,Atsuko Higashida,Toshio Kuroki	2009	4
10	Discovery of an Orally-Active Nonsteroidal Androgen Receptor Pure Antagonist and the Structure-Activity Relationships of Its Derivatives Chemical and Pharmaceutical Bulletin ·Kazutaka Tachibana,Ikuhiro Imaoka,Takuya Shiraishi,Hitoshi Yoshino,Mitsuaki Nakamura,Masateru Ohta,Hiromitsu Kawata,Kenji Taniguchi,Nobuyuki Ishikura,Toshiaki Tsunenari,Hidemi Saito,Masahiro Nagamuta,Toshito Nakagawa,Kenji Takanashi,Etsuro Onuma,Haruhiko Sato	2008	19
11	Discovery and structure–activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists Bioorganic & Medicinal Chemistry Letters ·Kazutaka Tachibana,Ikuhiro Imaoka,Hitoshi Yoshino,Nobuaki Kato,Mitsuaki Nakamura,Masateru Ohta,Hiromitsu Kawata,Kenji Taniguchi,Nobuyuki Ishikura,Masahiro Nagamuta,Etsuro Onuma,Haruhiko Sato	2007	7
12	Discovery of 7α-substituted dihydrotestosterones as androgen receptor pure antagonists and their structure–activity relationships Bioorganic & Medicinal Chemistry ·Kazutaka Tachibana,Ikuhiro Imaoka,Hitoshi Yoshino,Takashi Emura,Hirohumi Kodama,Yoshiyuki Furuta,Nobuaki Kato,Mitsuaki Nakamura,Masateru Ohta,Kenji Taniguchi,(unknown),(unknown),(unknown),(unknown)	2006	12
13	Total Synthesis of (±)-Scopadulin The Journal of Organic Chemistry ·S. M. Abdur Rahman,Hiroaki Ohno,Takashi Murata,Hitoshi Yoshino,Norifumi Satoh,Kazuo Murakami,Debasis Patra,Chuzo Iwata,Naoyoshi Maezaki,Tetsuaki Tanaka	2001	18
14	Preparation of Chitin/Polystyrene Hybrid Materials by Efficient Graft Copolymerization Based on Mercaptochitin Macromolecules ·Keisuke Kurita,Soichiro Hashimoto,Hitoshi Yoshino,Shigeru Ishii,Shin‐Ichiro Nishimura	1996	23
15	Synthetic Studies on Aphidicolane and Stemodane Diterpenes. IV. A Stereoselective Formal Total Synthesis of (.+-.)-Aphidicolin. Chemical and Pharmaceutical Bulletin ·Tetsuaki Tanaka,Kazuo Murakami,Osamu Okuda,Tetsuya Inoue,Takeshi Kuroda,Katsuhide Kamei,Takashi Murata,Hitoshi Yoshino,Takeshi Imanishi,Sangwon Kim,C. IWATA	1995	11
16	Lewis Acid-Mediated Stereoselective Spiroannelation: A Facile Access to Aphidicolane and Stemodane B/C/D Ring Systems. Chemical and Pharmaceutical Bulletin ·Tetsuaki Tanaka,Osamu Okuda,Kazuo Murakami,Hitoshi Yoshino,Hidenori Mikamiyama,Atsushi Kanda,Sang-Wong KIM,C. IWATA	1995	9
17	Synthetic Studies on Aphidicolane and Stemodane Diterpenes. III. An Alternative Stereoselective Access to Aphidicolane-Type B/C/D-Ring System. Chemical and Pharmaceutical Bulletin ·Tetsuaki Tanaka,Kaszuo MURAKAMI,Osamu Okuda,Takeshi Kuroda,Tetsuya Inoue,Katsuhide Kamei,Takashi Murata,Hitoshi Yoshino,Takeshi Imanishi,C. IWATA	1994	6
18	Preparation of tosylchitins as precursors for facile chemical modifications of chitin Macromolecules ·Keisuke Kurita,Hitoshi Yoshino,Koji Yokota,Motonari Ando,Satoshi Inoue,Shigeru Ishii,Shin‐Ichiro Nishimura	1992	56
19	Cationic and radical graft copolymerization of styrene onto iodochitin Macromolecules ·Keisuke Kurita,Satoshi Inoue,Kiichi Yamamura,Hitoshi Yoshino,Shigeru Ishii,Shin‐Ichiro Nishimura	1992	19
20	Coordination behavior of amine bases to the axial site of a (dibenzo[b,i][1,4,8,11]tetraazacyclotetradecinato)cobalt(II) Inorganica Chimica Acta ·Kazunori Sakata,Mamoru Hashimoto,Hitoshi Yoshino	1985	19

About Hitoshi Yoshino

Hitoshi Yoshino is a scholar working on Endocrinology, Diabetes and Metabolism, Biochemistry and Organic Chemistry, having authored 27 papers that have together received 528 indexed citations. Recurring topics across this work include Synthetic Organic Chemistry Methods (7 papers), Hormonal and reproductive studies (6 papers), Estrogen and related hormone effects (5 papers), Advanced Synthetic Organic Chemistry (4 papers), Asymmetric Synthesis and Catalysis (4 papers), Prostate Cancer Treatment and Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Biomaterials (113 citations), Endocrinology, Diabetes and Metabolism (128 citations) and Organic Chemistry (173 citations). Hitoshi Yoshino has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Shin‐Ichiro Nishimura, Keisuke Kurita, Shigeru Ishii, Satoshi Inoue, Tetsuaki Tanaka, Kazuo Murakami, Masanori Fukazawa, Yoshiyuki Suzuki, Yoshiki Kawabe and Takahiro Kawai. Their work appears in journals such as Proceedings of the National Academy of Sciences, Diabetes and Macromolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact